Add to ORKGWith the aim of examining central opioid influences on the control of luteinizing hormone (LH) secretion, we evaluated the LH response to naloxone, an opioid receptor antagonist, in patients affected by normo-, hyper-, and hypogonadotropic amenorrhea, polycystic ovarian disease and hyperprolactinemia. The results indicate that opioid influences are altered in well-defined pathologic conditions (hyperprolactinemia, obesity), in addition to being modified by gonadal steroids
To investigate whether enhanced LH levels of women with polycystic ovarian syndrome (PCOS) are the c...
To further evaluate the role exerted by endogenous opioids on LH secretion a naloxone challenge (0.0...
Endogenous opioid peptides have a tonic inhibitory control on LH secretion, participating in the fun...
With the aim of examining central opioid influences on the control of luteinizing hormone (LH) secre...
ecretion, we evaluated the LH response to naloxone, an opioid receptor antagonist, in patients affec...
The cause of the amenorrhea that occurs in patients with hyperprolactinemia is unknown. The involvem...
The cause of the amenorrhea that occurs in patients with hyperprolactinemia is unknown. The involvem...
The present study was designed to evaluate the influence of hyperandrogenemia on the activity of the...
The observation that heroin-addicted subjects are amenorrheic and/or hypogonadic suggested a possibl...
This study evaluated the activity of central opiate receptors modulating luteinizing hormone (LH) se...
To investigate whether enhanced LH levels of women with polycystic ovarian syndrome (PCOS) are the c...
To further evaluate the role exerted by endogenous opioids on LH secretion a naloxone challenge (0.0...
Endogenous opioid peptides have a tonic inhibitory control on LH secretion, participating in the fun...
With the aim of examining central opioid influences on the control of luteinizing hormone (LH) secre...
ecretion, we evaluated the LH response to naloxone, an opioid receptor antagonist, in patients affec...
The cause of the amenorrhea that occurs in patients with hyperprolactinemia is unknown. The involvem...
The cause of the amenorrhea that occurs in patients with hyperprolactinemia is unknown. The involvem...
The present study was designed to evaluate the influence of hyperandrogenemia on the activity of the...
The observation that heroin-addicted subjects are amenorrheic and/or hypogonadic suggested a possibl...
This study evaluated the activity of central opiate receptors modulating luteinizing hormone (LH) se...
To investigate whether enhanced LH levels of women with polycystic ovarian syndrome (PCOS) are the c...
To further evaluate the role exerted by endogenous opioids on LH secretion a naloxone challenge (0.0...
Endogenous opioid peptides have a tonic inhibitory control on LH secretion, participating in the fun...